52
Participants
Start Date
June 30, 2008
Primary Completion Date
October 31, 2011
Study Completion Date
October 31, 2011
BF2.649
up to 20mg per day
Placebo
up to 20mg per day
The University of Texas Southwestern Medical Center, Dallas
UT Southwestern Medical Center, Dallas
Collaborators (1)
Bioprojet
OTHER
Stanley Medical Research Institute
OTHER
University of Texas Southwestern Medical Center
OTHER